185 related articles for article (PubMed ID: 37081824)
1. The invariant chain CD74 protein is a cell surface binding partner of TIMP-1 in breast cancer cells.
Høeberg M; Noer JB; Vistesen MV; Bartels A; Bech EM; Nygård SB; Lademann U; Stenvang J; Liu S; Fuglsang AT; Brünner N; Moreira JMA
Mol Oncol; 2023 Aug; 17(8):1595-1612. PubMed ID: 37081824
[TBL] [Abstract][Full Text] [Related]
2. Identification of invariant chain CD74 as a functional receptor of tissue inhibitor of metalloproteinases-1 (TIMP-1).
Schoeps B; Eckfeld C; Flüter L; Keppler S; Mishra R; Knolle P; Bayerl F; Böttcher J; Hermann CD; Häußler D; Krüger A
J Biol Chem; 2021 Sep; 297(3):101072. PubMed ID: 34391782
[TBL] [Abstract][Full Text] [Related]
3. Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential.
Figueira RC; Gomes LR; Neto JS; Silva FC; Silva ID; Sogayar MC
BMC Cancer; 2009 Jan; 9():20. PubMed ID: 19144199
[TBL] [Abstract][Full Text] [Related]
4. TGF-β1 modulates the homeostasis between MMPs and MMP inhibitors through p38 MAPK and ERK1/2 in highly invasive breast cancer cells.
Gomes LR; Terra LF; Wailemann RA; Labriola L; Sogayar MC
BMC Cancer; 2012 Jan; 12():26. PubMed ID: 22260435
[TBL] [Abstract][Full Text] [Related]
5. Tissue Inhibitor of Metalloproteinases-1 Interacts with CD74 to Promote AKT Signaling, Monocyte Recruitment Responses, and Vascular Smooth Muscle Cell Proliferation.
Ebert S; Zang L; Ismail N; Otabil M; Fröhlich A; Egea V; Ács S; Hoeberg M; Berres ML; Weber C; Moreira JMA; Ries C; Bernhagen J; El Bounkari O
Cells; 2023 Jul; 12(14):. PubMed ID: 37508563
[TBL] [Abstract][Full Text] [Related]
6. Identification of CD63 as a tissue inhibitor of metalloproteinase-1 interacting cell surface protein.
Jung KK; Liu XW; Chirco R; Fridman R; Kim HR
EMBO J; 2006 Sep; 25(17):3934-42. PubMed ID: 16917503
[TBL] [Abstract][Full Text] [Related]
7. Low-density lipoprotein receptor-related protein-1 mediates endocytic clearance of tissue inhibitor of metalloproteinases-1 and promotes its cytokine-like activities.
Thevenard J; Verzeaux L; Devy J; Etique N; Jeanne A; Schneider C; Hachet C; Ferracci G; David M; Martiny L; Charpentier E; Khrestchatisky M; Rivera S; Dedieu S; Emonard H
PLoS One; 2014; 9(7):e103839. PubMed ID: 25075518
[TBL] [Abstract][Full Text] [Related]
8. TIMP-1 via TWIST1 induces EMT phenotypes in human breast epithelial cells.
D'Angelo RC; Liu XW; Najy AJ; Jung YS; Won J; Chai KX; Fridman R; Kim HR
Mol Cancer Res; 2014 Sep; 12(9):1324-33. PubMed ID: 24895412
[TBL] [Abstract][Full Text] [Related]
9. Directed evolution of the metalloproteinase inhibitor TIMP-1 reveals that its N- and C-terminal domains cooperate in matrix metalloproteinase recognition.
Raeeszadeh-Sarmazdeh M; Greene KA; Sankaran B; Downey GP; Radisky DC; Radisky ES
J Biol Chem; 2019 Jun; 294(24):9476-9488. PubMed ID: 31040180
[TBL] [Abstract][Full Text] [Related]
10. Regulation of Tumor Metabolism and Extracellular Acidosis by the TIMP-10-CD63 Axis in Breast Carcinoma.
Najy AJ; Jung YS; Kim S; Fridman R; Kim HC
Cells; 2021 Oct; 10(10):. PubMed ID: 34685701
[TBL] [Abstract][Full Text] [Related]
11. Increased acinar damage of salivary glands of patients with Sjögren's syndrome is paralleled by simultaneous imbalance of matrix metalloproteinase 3/tissue inhibitor of metalloproteinases 1 and matrix metalloproteinase 9/tissue inhibitor of metalloproteinases 1 ratios.
Pérez P; Kwon YJ; Alliende C; Leyton L; Aguilera S; Molina C; Labra C; Julio M; Leyton C; González MJ
Arthritis Rheum; 2005 Sep; 52(9):2751-60. PubMed ID: 16142742
[TBL] [Abstract][Full Text] [Related]
12. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
13. Purification and characterization of bioactive his6-tagged recombinant human tissue inhibitor of metalloproteinases-1 (TIMP-1) protein expressed at high yields in mammalian cells.
Vinther L; Lademann U; Andersen EV; Højrup P; Thaysen-Andersen M; Krogh BO; Viuff B; Brünner N; Stenvang J; Moreira JM
Protein Expr Purif; 2014 Sep; 101():157-64. PubMed ID: 24998777
[TBL] [Abstract][Full Text] [Related]
14. Tumour-associated tenascin-C isoforms promote breast cancer cell invasion and growth by matrix metalloproteinase-dependent and independent mechanisms.
Hancox RA; Allen MD; Holliday DL; Edwards DR; Pennington CJ; Guttery DS; Shaw JA; Walker RA; Pringle JH; Jones JL
Breast Cancer Res; 2009; 11(2):R24. PubMed ID: 19405959
[TBL] [Abstract][Full Text] [Related]
15. Tissue Inhibitor of Metalloproteinase-1 Promotes Polymorphonuclear Neutrophil (PMN) Pericellular Proteolysis by Anchoring Matrix Metalloproteinase-8 and -9 to PMN Surfaces.
Wang X; Rojas-Quintero J; Wilder J; Tesfaigzi Y; Zhang D; Owen CA
J Immunol; 2019 Jun; 202(11):3267-3281. PubMed ID: 31019060
[TBL] [Abstract][Full Text] [Related]
16. Reactive site mutations in tissue inhibitor of metalloproteinase-3 disrupt inhibition of matrix metalloproteinases but not tumor necrosis factor-alpha-converting enzyme.
Wei S; Kashiwagi M; Kota S; Xie Z; Nagase H; Brew K
J Biol Chem; 2005 Sep; 280(38):32877-82. PubMed ID: 16079149
[TBL] [Abstract][Full Text] [Related]
17. Establishment of Structure-Function Relationship of Tissue Inhibitor of Metalloproteinase-1 for Its Interaction with CD63: Implication for Cancer Therapy.
Warner RB; Najy AJ; Jung YS; Fridman R; Kim S; Kim HC
Sci Rep; 2020 Feb; 10(1):2099. PubMed ID: 32034211
[TBL] [Abstract][Full Text] [Related]
18. TIMP-1 overexpression promotes tumorigenesis of MDA-MB-231 breast cancer cells and alters expression of a subset of cancer promoting genes in vivo distinct from those observed in vitro.
Bigelow RL; Williams BJ; Carroll JL; Daves LK; Cardelli JA
Breast Cancer Res Treat; 2009 Sep; 117(1):31-44. PubMed ID: 18787947
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression.
Hofmann UB; Westphal JR; Waas ET; Zendman AJ; Cornelissen IM; Ruiter DJ; van Muijen GN
Br J Cancer; 1999 Nov; 81(5):774-82. PubMed ID: 10555745
[TBL] [Abstract][Full Text] [Related]
20. Proteolytic imbalance is reversed after therapeutic surgery in breast cancer patients.
Giannelli G; Erriquez R; Fransvea E; Daniele A; Trerotoli P; Schittulli F; Grano M; Quaranta M; Antonaci S
Int J Cancer; 2004 May; 109(5):782-5. PubMed ID: 14999790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
